Pharmacy Focus: Psychedelic Pharmacy - Potential Drug-Drug Interactions and Adverse Effects With Psychedelic Medicines

Podcast

Kelan Thomas, PharmD, MS, discussed potential adverse effects and drug-drug interactions that pharmacists should be aware of with psychedelic medicines.

In the latest episode, Alana Hippensteele of Pharmacy Times sat down with Kelan Thomas, PharmD, MS, to discuss potential adverse effects and drug-drug interactions that pharmacists should be aware of with psychedelic medicines.

Related Videos
Credit: Adobe Stock - Tierney
https://www.youtube.com/watch?v=Q-WCvWaAcC8
Yaruniv-Studio - stock.adobe.com
Technician- © pharmacytimes
Pills on a background of a one hundred American dollar bill | Image credit: Cagkan - stock.adobe.com
Credit: Cagkan - stock.adobe.com
Specialty pharmacy illustration | Image credit: BillionPhotos.com - stock.adobe.com
Related Content

MDMA-Assisted Therapy Demonstrates Significant Reductions in Post-Traumatic Stress Disorder Symptoms in Phase 3 Study

September 15th 2023

Pharmacy Focus: Student Edition - Fostering Inclusivity: Scholarships for Black Student Pharmacists

September 18th 2023

Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis

September 13th 2023

Pharmacy Focus: Turning the Tide On Obesity - Episode 2

September 13th 2023

Phase 3 Trial Shows Combined Nivolumab, Ipilimumab Treatment Improved OS in Patients With mNSCLC

September 12th 2023

California Bill to Decriminalize Natural Psychedelics Passes State Legislature on the Heels of Phase 2 Data Showing Safety, Efficacy of Psilocybin for MDD

September 11th 2023

MDMA-Assisted Therapy Demonstrates Significant Reductions in Post-Traumatic Stress Disorder Symptoms in Phase 3 Study

September 15th 2023

Pharmacy Focus: Student Edition - Fostering Inclusivity: Scholarships for Black Student Pharmacists

September 18th 2023

Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis

September 13th 2023

Pharmacy Focus: Turning the Tide On Obesity - Episode 2

September 13th 2023

Phase 3 Trial Shows Combined Nivolumab, Ipilimumab Treatment Improved OS in Patients With mNSCLC

September 12th 2023

California Bill to Decriminalize Natural Psychedelics Passes State Legislature on the Heels of Phase 2 Data Showing Safety, Efficacy of Psilocybin for MDD

September 11th 2023

MDMA-Assisted Therapy Demonstrates Significant Reductions in Post-Traumatic Stress Disorder Symptoms in Phase 3 Study

September 15th 2023

Pharmacy Focus: Student Edition - Fostering Inclusivity: Scholarships for Black Student Pharmacists

September 18th 2023

Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis

September 13th 2023

Pharmacy Focus: Turning the Tide On Obesity - Episode 2

September 13th 2023

Phase 3 Trial Shows Combined Nivolumab, Ipilimumab Treatment Improved OS in Patients With mNSCLC

September 12th 2023

California Bill to Decriminalize Natural Psychedelics Passes State Legislature on the Heels of Phase 2 Data Showing Safety, Efficacy of Psilocybin for MDD

September 11th 2023
© 2023 MJH Life Sciences

All rights reserved.